TULSA, Okla., March 13, 2017 -- Educational Development Corporation (“EDC”) (NASDAQ:EDUC) (http://www.edcpub.com) today reports record unaudited net revenues for fiscal ended February 28, 2017 (unaudited).
Randall White, CEO of Educational Development Corporation, announced that the Company has surpassed our previous net revenues milestone with $106 million for the 2017 fiscal year ending February 28, 2017, compared to $63.7 million for last year. The sales increase was primarily generated by the home business division, Usborne Books & More (UBAM) with an increase of 84% over the prior year.
About Educational Development Corporation
EDC is a publishing company specializing in books for children. EDC is the sole American distributor of the UK-based Usborne Books and owns Kane Miller Books, specializing in children’s literature from around the world. EDC’s current catalog contains over 2,300 titles, with new additions semi-annually. Both Usborne and Kane Miller products are sold via 5,000 retail outlets and by over 20,000 direct sales consultants nationally.
Contact: Educational Development Corporation Randall White, (918) 622-4522


Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



